Literature review revealed that AML with co-occurrence of <i>CBFB-MYH11</i> and <i>BCR-ABL1</i> gene rearrangements was involved by only a small number of cases with de novo and therapy-related AML. This evidence concerns the gene MYH11 and acute myeloid leukemia.